European Journal of Clinical Pharmacology

, Volume 64, Issue 2, pp 115–125

Do we learn the right things from clinical trials?

Review Article

DOI: 10.1007/s00228-007-0411-4

Cite this article as:
Garattini, S. & Bertele’, V. Eur J Clin Pharmacol (2008) 64: 115. doi:10.1007/s00228-007-0411-4


Added value Adverse reactions Clinical end-points Clinical drug trials Comparators Design Conflicts of interest Randomization 

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.“Mario Negri” Institute for Pharmacological ResearchMilanItaly

Personalised recommendations